Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Weekly docetaxel as neoadjuvant chemotherapy for stage II and III breast cancer: efficacy and correlation with biological markers in a phase II, multicenter studyLaura G Estévez, José Miguel Cuevas, Antonio Antón, et al.
Acta Medica Portuguesa|May 29, 2016
Parcial Nephrectomies - results of 12 years from an Oncology InstitutionRui Freitas, Ricardo Cruz, Luís Antunes, et al.
DNA and Cell Biology|September 30, 2010
Functional and epigenetic characterization of the KRT19 gene in renal cell neoplasmsFilipa Paiva, Sara Duarte-Pereira, Vera Lúcia Costa, et al.
Seminars in Oncology|June 17, 2004
Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy in stage II and III breast cancer patients: preliminary results of a phase II and pharmacogenomic studyLaura G Estévez, Pedro Sánchez-Rovira, Manuel Dómine, et al.
Plos One|August 17, 2013
Improvement of a predictive model of castration-resistant prostate cancer: functional genetic variants in TGFβ1 signaling pathway modulationAna L Teixeira, Mónica Gomes, Augusto Nogueira, et al.
Journal of Clinical Medicine|October 26, 2024
Renal Cell Carcinoma with Venous Tumor Thrombus: 15 Years of Experience in an Oncology CenterGabriel Faria-Costa, Rui Freitas, Isaac Braga, et al.
Journal of Cellular and Molecular Medicine|July 30, 2013
Deregulation of PAX2 expression in renal cell tumours: mechanisms and potential use in differential diagnosisPatrícia Patrício, João Ramalho-Carvalho, Pedro Costa-Pinheiro, et al.
Oncotarget|December 22, 2017
Plasmatic miR-210, miR-221 and miR-1233 profile: potential liquid biopsies candidates for renal cell carcinomaFrancisca Dias, Ana Luísa Teixeira, Marta Ferreira, et al.
American Journal of Cancer Research|September 21, 2016
Prognostic significance of MST1R dysregulation in renal cell tumorsAna S Pires-Luís, Márcia Vieira-Coimbra, Maria João Ferreira, et al.
Epigenetics|November 4, 2017
SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastizationMaria João Ferreira, Ana Sílvia Pires-Luís, Márcia Vieira-Coimbra, et al.
Pageof 6